Trexquant Investment’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Buy
+560,637
New +$4.14M 0.03% 763
2025
Q4
Sell
-258,002
Closed -$3M 1633
2025
Q3
$3M Sell
258,002
-449,957
-64% -$5.44M 0.03% 746
2025
Q2
$8.72M Buy
707,959
+572,472
+423% +$6.32M 0.1% 299
2025
Q1
$835K Buy
135,487
+115,819
+589% +$1.2M 0.01% 1144
2024
Q4
$159K Buy
+19,668
New +$196K ﹤0.01% 1490

Other funds holding CRMD

Trexquant Investment's CRMD Position: Q1 2026 in Review

Trexquant Investment opened a new position in CorMedix (CRMD) in Q1 2026: 560,637 shares worth $3.81M. The stake represents 0.03% of the portfolio and ranks #763 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in CRMD as recently as Q3 2025.

Trexquant Investment first reported a position in CRMD in Q4 2024 and has held it in 5 quarters since. The position peaked at $8.72M in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Trexquant Investment held 560,637 shares of CorMedix worth $3.81M as of Q1 2026.
  • CorMedix was a new Trexquant Investment position in Q1 2026.
  • CorMedix made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #763 holding.
  • Trexquant Investment first reported a position in CorMedix in Q4 2024 and has held it in 5 quarters since.
  • Trexquant Investment's CorMedix position peaked at $8.72M in Q2 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.